Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Due to the relative strength of DBP expression in α cells, the images have been overexposed to allow visualization of DBP in the non-α-cell compartment (representative images are shown; scale bar represents 85 μm; n = 13 islets, 3 animals).(D) Expression of Gc, which encodes DBP, is barely detectable in DBP−/− islets using Taqman assays (n = 4 to 5 animals).(E and F) Serum 25(OH)D (E) and 1,25(OH)2D (F) levels are ∼2-fold and 4-fold lowered in DBP+/− and DBP−/− animals, respectively (n = 4 to 6 animals; one-way ANOVA with Bonferroni’s multiple comparisons test).(G and H) Glucose tolerance curves (G) and area under the curve (AUC) (H) are similar in DBP+/+ and DBP−/− mice (n = 7 to 11 animals; two-way repeated-measure ANOVA with Bonferroni’s multiple comparison test or unpaired t test).(I) Pyruvate tolerance is similar in DBP+/+ and DBP−/− mice (n = 3 to 4; two-way repeated-measure ANOVA with Bonferroni’s multiple comparison test or unpaired t test).(J and K) Insulin sensitivity tends to be increased in DBP−/− versus DBP+/+ mice (J), as also shown by the AUC (K) (n = 12 animals; two-way repeated-measure ANOVA with Bonferroni’s multiple comparisons test or unpaired t test).(L) % decrease in glucose is greater in DBP−/− versus DBP+/+ mice 30 min post-insulin injection (n = 12 animals; two-way ANOVA with Fisher’s least significant difference [LSD]).(M) Glucagon secretion in response to insulin bolus is impaired in DBP−/− mice (n = 5 animals; two-way ANOVA with Bonferroni’s multiple comparisons test).(N) Body weight/growth curve is similar in DBP+/+ and DBP−/− mice (n = 3 to 4; two-way repeated-measure ANOVA with Bonferroni’s multiple comparison test or unpaired t test).(O) Gctm1.1(KOMP)Vlcg mice with homozygous loss of Gc (mut) present with decreases in fed blood glucose compared to controls (con) (n = 7 homozygous Gc-null males and 6 Gc-null females versus 666 male and 654 female controls; Mixed Model framework, linear mixed-effects model, equation without weight; both sexes classified equally).

Source: DBP Is Deleted in α Cells of DBP−/− Mice. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Other blinding reported · Animal research reported

Reported blinded roles: investigators.

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

DBP−/− mice were generated using a PGK-promoter/neomycin cassette to disrupt exon 5 of the mouse Gc gene, as described ().

Source: Methods.

Investigators were blinded to animal identity.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion

Study design awaiting verification · Cell Reports · 2020

Original publication title

Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion

Katrina Viloria; Daniela Nasteska; Linford J.B. Briant; Silke Heising; Dean P. Larner; Nicholas H.F. Fine; Fiona B. Ashford; Gabriela da Silva Xavier; Maria Jiménez Ramos; Annie Hasib; Federica Cuozzo; Jocelyn E. Manning Fox; Patrick E. MacDonald; Ildem Akerman; Gareth G. Lavery; Christine Flaxman; Noel G. Morgan; Sarah J. Richardson; Martin Hewison; David J. Hodson

© 2020 The Author(s)

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Summary

Vitamin-D-binding protein (DBP) or group-specific component of serum (GC-globulin) carries vitamin D metabolites from the circulation to target tissues. DBP is highly localized to the liver and pancreatic α cells. Although DBP serum levels, gene polymorphisms, and autoantigens have all been associated with diabetes risk, the underlying mechanisms remain unknown. Here, we show that DBP regulates α cell morphology, α cell function, and glucagon secretion. Deletion of DBP leads to smaller and hyperplastic α cells, altered Na+ channel conductance, impaired α cell activation by low glucose, and reduced rates of glucagon secretion both in vivo and in vitro.

Mechanistically, this involves reversible changes in islet microfilament abundance and density, as well as changes in glucagon granule distribution. Defects are also seen in β cell and δ cell function. Immunostaining of human pancreata reveals generalized loss of DBP expression as a feature of late-onset and long-standing, but not early-onset, type 1 diabetes. Thus, DBP regulates α cell phenotype, with implications for diabetes pathogenesis.

Highlights

  • •

    Vitamin-D-binding protein (DBP) is highly expressed in pancreatic α cells

  • •

    Glucagon secretion and insulin tolerance are altered in mice lacking DBP

  • •

    DBP-null α cells possess an abnormal actin cytoskeleton and are dysfunctional

  • •

    DBP levels are decreased in α cells of donors with late-onset type 1 diabetes

Viloria et al. show that vitamin-D-binding protein (DBP) contributes to insulin tolerance and circulating glucagon levels in mice. Loss of DBP leads to smaller, hyperplastic α cells, with increased abundance of F-actin microfilaments. These changes are associated with decreased α cell activity, re-distribution of glucagon granules, and impaired glucagon secretion.

Authors’ abstract

Summary

Vitamin-D-binding protein (DBP) or group-specific component of serum (GC-globulin) carries vitamin D metabolites from the circulation to target tissues. DBP is highly localized to the liver and pancreatic α cells. Although DBP serum levels, gene polymorphisms, and autoantigens have all been associated with diabetes risk, the underlying mechanisms remain unknown. Here, we show that DBP regulates α cell morphology, α cell function, and glucagon secretion. Deletion of DBP leads to smaller and hyperplastic α cells, altered Na+ channel conductance, impaired α cell activation by low glucose, and reduced rates of glucagon secretion both in vivo and in vitro.

Mechanistically, this involves reversible changes in islet microfilament abundance and density, as well as changes in glucagon granule distribution. Defects are also seen in β cell and δ cell function. Immunostaining of human pancreata reveals generalized loss of DBP expression as a feature of late-onset and long-standing, but not early-onset, type 1 diabetes. Thus, DBP regulates α cell phenotype, with implications for diabetes pathogenesis.

Highlights

  • •

    Vitamin-D-binding protein (DBP) is highly expressed in pancreatic α cells

  • •

    Glucagon secretion and insulin tolerance are altered in mice lacking DBP

  • •

    DBP-null α cells possess an abnormal actin cytoskeleton and are dysfunctional

  • •

    DBP levels are decreased in α cells of donors with late-onset type 1 diabetes

Viloria et al. show that vitamin-D-binding protein (DBP) contributes to insulin tolerance and circulating glucagon levels in mice. Loss of DBP leads to smaller, hyperplastic α cells, with increased abundance of F-actin microfilaments. These changes are associated with decreased α cell activity, re-distribution of glucagon granules, and impaired glucagon secretion.

Publication and source details

Original title: Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion

Katrina Viloria; Daniela Nasteska; Linford J.B. Briant; Silke Heising; Dean P. Larner; Nicholas H.F. Fine; Fiona B. Ashford; Gabriela da Silva Xavier; Maria Jiménez Ramos; Annie Hasib; Federica Cuozzo; Jocelyn E. Manning Fox; Patrick E. MacDonald; Ildem Akerman; Gareth G. Lavery; Christine Flaxman; Noel G. Morgan; Sarah J. Richardson; Martin Hewison; David J. Hodson

Cell Reports · 2020

∗ Corresponding author m.hewison@bham.ac.uk∗∗ Corresponding author d.hodson@bham.ac.uk
7

Lead Contact

© 2020 The Author(s)2020https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:49:37.789677+00:00

DOI: 10.1016/j.celrep.2020.107761 · PMC7302426